You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MBX Sale Disclosure
Hoerter Steven L. · SEC Form 4 · Filed Nov 12, 2026
Sale
Calculated transaction value
$268.23K
Hoerter Steven L. Chairman, President And CEO
MBX
MBX Biosciences
MBX
Transaction date
Nov 10, 2026
Public filing date
Nov 12, 2026
Filing lag
Filed 2 days later
MBX daily price context
Close on/before transaction
$56.33
Nov 10, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,893 shares @ $54.82
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-457015
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$268.23K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Mbx Biosciences, Inc. MBX Current | Sale | Nov 10, 2026 | $268.23K |